Literature DB >> 14966109

TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies.

Boris Pasche, Virginia Kaklamani, Nanjiang Hou, Taya Young, Alfred Rademaker, Paolo Peterlongo, Nathan Ellis, Kenneth Offit, Trinidad Caldes, Michael Reiss, Tongzhang Zheng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14966109     DOI： 10.1200/JCO.2004.99.271

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  33 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

Review 2.  Genetic susceptibility to cancer: the role of polymorphisms in candidate genes.

Authors:  Linda M Dong; John D Potter; Emily White; Cornelia M Ulrich; Lon R Cardon; Ulrike Peters
Journal:  JAMA       Date:  2008-05-28       Impact factor: 56.272

3.  The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis.

Authors:  Xueli Zhang; Liang Wu; Youhua Sheng; Wenhua Zhou; Zhongming Huang; Jun Qu; Ganglong Gao; Duan Cai; Ming Zhang
Journal:  Mol Biol Rep       Date:  2011-08-20       Impact factor: 2.316

4.  Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.

Authors:  Wei Guo; Zhiming Dong; Yanli Guo; Zhifeng Chen; Zhibin Yang; Gang Kuang
Journal:  Mol Biol Rep       Date:  2011-07-22       Impact factor: 2.316

Review 5.  Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.

Authors:  Barbara Jung; Jonas J Staudacher; Daniel Beauchamp
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

6.  Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs.

Authors:  Boris Pasche; Kari B Wisinski; Maureen Sadim; Virginia Kaklamani; Michael J Pennison; Qinghua Zeng; Naresh Bellam; Jacquelyn Zimmerman; Nengjun Yi; Kui Zhang; John Baron; Daniel O Stram; M Geoffrey Hayes
Journal:  J Exp Clin Cancer Res       Date:  2010-05-25

7.  TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.

Authors:  Ru-Yan Liao; Chen Mao; Li-Xin Qiu; Hong Ding; Qing Chen; Hai-Feng Pan
Journal:  Mol Biol Rep       Date:  2009-11-01       Impact factor: 2.316

8.  TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.

Authors:  J Skoglund Lundin; J Vandrovcova; B Song; X Zhou; M Zelada-Hedman; B Werelius; R S Houlston; A Lindblom
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

9.  The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study.

Authors:  Adela Castillejo; Trinidad Mata-Balaguer; Carla Guarinos; María-Isabel Castillejo; Ana Martínez-Cantó; Víctor-Manuel Barberá; Paola Montenegro; Enrique Ochoa; Rafael Lázaro; Carmen Guillén-Ponce; Alfredo Carrato; José-Luís Soto
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

10.  The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.

Authors:  Adela Castillejo; Trinidad Mata-Balaguer; Paola Montenegro; Enrique Ochoa; Rafael Lázaro; Ana Martínez-Cantó; María-Isabel Castillejo; Carla Guarinos; Víctor-Manuel Barberá; Carmen Guillén-Ponce; Alfredo Carrato; José-Luís Soto
Journal:  BMC Cancer       Date:  2009-06-18       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.